N.CER Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Series A
- Investors
-
11
N.CER General Information
Description
Developer of diagnostic systems designed to detect dementia. The company develops a medical device using olfactory response and near-infrared spectroscopy that screens out early dementia that is difficult to distinguish with the existing questionnaire or imaging method, enabling doctors to diagnose early dementia based on changes in brain blood flow during sensory stimulation.
Contact Information
Website
ncerebro-en.imweb.meCorporate Office
- Room 316, E3, 123
- Cheomdangwagi-ro, Buk-gu
- Gwangju
- South Korea
Corporate Office
- Room 316, E3, 123
- Cheomdangwagi-ro, Buk-gu
- Gwangju
- South Korea
N.CER Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series A) | 02-Apr-2026 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 3. Early Stage VC (Series A) | 22-Aug-2021 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Feb-2020 | $430K | Completed | Generating Revenue | ||
| 1. Seed Round | 15-Jan-2020 | $430K | $430K | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
N.CER Patents
N.CER Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025042241-A1 | Fragrance recommendation device and system | Inactive | 24-Aug-2023 | ||
| WO-2023017941-A1 | System for comprehensive analysis of dementia or degenerative brain disease | Inactive | 11-Aug-2021 | ||
| WO-2023017940-A1 | Dementia examination device mounted for dementia level classification, and method for classifying dementia levels using same | Inactive | 10-Aug-2021 | ||
| WO-2022182093-A1 | Apparatus and method for analyzing exercise amount and exercise intensity applied to muscles | Inactive | 26-Feb-2021 | ||
| WO-2022108297-A1 | Device for alleviating dementia symptoms | Inactive | 19-Nov-2020 | A61M21/00 |
N.CER Signals
N.CER Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Colopl Next | Corporate Venture Capital | Minority | ||
| Cosine Investment | Venture Capital | Minority | ||
| DT & Investment | Corporate Venture Capital | Minority | ||
| Enlight Ventures | Venture Capital | Minority | ||
| G1 (South Korea) | Corporation | Minority |
N.CER FAQs
-
When was N.CER founded?
N.CER was founded in 2019.
-
Where is N.CER headquartered?
N.CER is headquartered in Gwangju, South Korea.
-
What is the size of N.CER?
N.CER has 6 total employees.
-
What industry is N.CER in?
N.CER’s primary industry is Diagnostic Equipment.
-
Is N.CER a private or public company?
N.CER is a Private company.
-
What is N.CER’s current revenue?
The current revenue for N.CER is .
-
How much funding has N.CER raised over time?
N.CER has raised $2.42M.
-
Who are N.CER’s investors?
Colopl Next, Cosine Investment, DT & Investment, Enlight Ventures, and G1 (South Korea) are 5 of 11 investors who have invested in N.CER.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process